年龄相关性黄斑变性中非渗出性黄斑新生血管的患病率研究
这项前瞻性多中心队列研究纳入862例单眼新发渗出性AMD患者,其中550眼在首次抗VEGF注射后30天内完成OCT和OCT-A。基线时20.4%存在双层征(DLS),8.5%存在非渗出性黄斑新生血管(neMNV);结论提示DLS并非neMNV的良好替代标志物。
要点
- 单眼新发渗出性AMD患者对侧眼中,OCT显示DLS者占20.4%(95%CI 17.1%-24.0%)。
- 对侧眼neMNV患病率为8.5%(95%CI 6.4%-11.3%),其中89.36%位于DLS内。
核心结论
- 在单眼新发渗出性AMD患者中,对侧眼OCT显示DLS者约五分之一,但其中仅40%经OCT-A证实存在neMNV,提示DLS并非neMNV的良好替代标志物。
研究设计与样本
- 前瞻性观察性队列多中心研究,于2021年1月至2025年6月在英国开展,纳入862例单眼新发渗出性AMD并接受抗VEGF治疗的患者。
- 采用逻辑回归模型评估与neMNV和DLS相关的单变量及校正关联。
主要发现
- 550眼中,112眼(20.4%;95%CI 17.1%-24.0%)存在DLS,47眼(8.5%;95%CI 6.4%-11.3%)存在neMNV。
- 47眼neMNV中,42眼(89.36%)位于DLS内,3眼(6.4%)位于纤维血管不规则浅脱离(FIPED)中,2眼(4.3%)位于玻璃膜疣下方。
关键数值与推荐
- neMNV定义为OCT-A上可见新生血管网,DLS定义为OCT上RPE与Bruch膜之间的双层结构。
- 厚DLS与薄DLS的划分标准原文未报告具体阈值。
临床怎么用
- 对单眼新发渗出性AMD患者的对侧眼,OCT发现DLS时应警惕neMNV可能,但不应仅凭DLS诊断neMNV。
- 厚DLS眼neMNV患病率更高,可能需要更密切的OCT-A监测。
- DLS作为neMNV替代标志物的敏感性有限,临床试验样本量估算需谨慎。
局限性
- 仅550眼(63.8%)在30天内完成OCT-A,可能存在选择偏倚。
- 原文未报告厚DLS与薄DLS的具体定义阈值。
- 研究结论基于英国多中心人群,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Nonexudative macular neovascularization (neMNV) is a risk factor for exudation in fellow eyes of patients with unilateral exudative age-related macular degeneration (AMD). Accurate estimation of prevalence of neMNV is required for sample size calculations for clinical trials evaluating novel interventions to delay exudation from neMNV. Certain dimensions of double-layer sign (DLS) on optical coherence tomography (OCT) are often regarded as a surrogate for neMNV. OBJECTIVE: To assess the prevalence of fellow-eye neMNV on OCT angiography (OCT-A) in eyes with AMD with DLS on OCT among patients with unilateral new-exudative AMD in the first eye. DESIGN, SETTING, AND PARTICIPANTS: This prospective observational cohort multicenter study took place in the United Kingdom from January 2021 through June 2025. The study included 862 participants with OCT and OCT-A within 3 months of initiation of anti-vascular endothelial growth factor (VEGF) therapy, of whom 550 (63.8%) had both OCT and OCT-A performed within 30 days of the date of the first anti-VEGF injection to the fellow eye. These data were analyzed from July 2025 through October 2025. MAIN OUTCOMES AND MEASURES: Prevalence of DLS, neMNV, and assessment of univariable and adjusted associations with neMNV and DLS were assessed using logistic regression models. RESULTS: Among 550 eyes (mean [SD] participant age, 78.0 [7.6] years; 315 female [57.3%] and 235 male [42.7%]), 112 (20.4%; 95% CI [Wilson score], 17.1%-24.0%) had DLS and 47 eyes (8.5%; 95% CI [Wilson score], 6.4%-11.3%) had neMNV at baseline, including 42 (89.36%) within DLS, 3 (6.4%) in fibrovascular irregular shallow-pigment epithelial detachment, and 2 (4.3%) below drusen. Prevalence of neMNV was higher among eyes with thick DLS (n = 36 [48%]) compared with those with thin DLS (16.2%; n = 6; difference = -31.8%; 95% CI [Wilson score], -46.9% to -11.7%; P = .002). CONCLUSIONS AND RELEVANCE: While 1 in 5 fellow eyes had DLS on OCT among patients with unilateral new-onset exudative AMD in the first eye, the prevalence of neMNV on OCT-A was only 40% among these eyes with DLS. These results suggest DLS on OCT in fellow eyes of patients with new-onset exudative AMD in the first eye is not a good surrogate for neMNV. TRIAL REGISTRATION: ISRCTN registry Identifier: ISRTCTN13798759.
引用
- Thottarath S, Gurudas S, Kubravi S, et al. Nonexudative Macular Neovascularization in Age-Related Macular Degeneration. JAMA Ophthalmol. 2026. PMID: 41954906. doi:10.1001/jamaophthalmol.2026.0459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。